GPC3 Promotes Lung Squamous Cell Carcinoma Progression and HLA-A2-Restricted GPC3 Antigenic Peptide-Modified Dendritic Cell-Induced Cytotoxic T Lymphocytes to Kill Lung Squamous Cell Carcinoma Cells

Figure 5

HLA-A2 expression in LUSC cells and peripheral blood of LUSC patients and identification of HLA-A2-restricted GPC3 antigenic peptides. (a) Expression of HLA-A2 in NCI-H226 cells, SK-MES-1 cells, and the peripheral blood of LUSC patients using flow cytometry. (b) Identification of HLA-A2-restricted GPC3 antigenic peptides using high-performance liquid chromatography (left) and mass spectrum (right).

(a)

(b)